Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
ZVSA ZyVersa Therapeutics
2.020-0.160-7.34%
Close
02/08 16:00 ET
2.0200.0000.00%
Pre Mkt Price 02/09 04:09 ET
High
2.180
Open
2.180
Turnover
109.43K
Low
1.960
Pre Close
2.180
Volume
52.69K
Pre-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Ford Motor, Atlassian, Bill.com Among Premarket Losers' Pack
Tenax, Innovative Top Healthcare Gainers; OncoSec, Vera Among Losers
Why Meta Platforms Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
GainersTenax Therapeutics, Inc (NASDAQ:TENX) shares rose 172.8% to $4.61 in pre-market trading. Tenax was granted a Notice of Allowance for U.S. Patent application for use of IV levosimendan in pulmo
ZyVersa Therapeutics Offering Stock and Warrants >ZVSA
ZyVersa Therapeutics Files Common Stock Offering, No Amount Given
Press Release: ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4)
ZyVersa Therapeutics Reports Inducement Grant to Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(c)(4) WESTON, Fla., Jan. 27, 2023 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc.
ZyVersa Therapeutics to Present at BIO CEO & Investor Conference
CEO Stephen C. Glover to provide key updates on the development status of ZyVersa's Phase 2a-ready cholesterol efflux mediator VAR 200 for renal disease and inflammasome ASC inhibitor, IC 100 WESTON, Fla., Jan. 25,
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Genius Group Limited (NYSE:GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.NeuroSense Therapeutics L
Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Gainers Tricida, Inc. (NASDAQ:TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.Huadi International Group Co., Ltd. (NASDAQ:HUDI) rose 26.7% to $7.16 in pre-market tradi
LXRX, PGNY and ANGI Are Among After Hour Movers
Company Overview
More
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It leverages advanced & proprietary technologies to develop product candidates in the areas of renal and inflammatory diseases. The company is headquartered in Weston, FL.
CEO： Mr. Stephen C. Glover
Market： NASDAQ
Listing Date： 12/21/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet